TITLE:
COVID-19 in Bouake (Côte D’Ivoire): Comparative Study of the Epidemiological, Clinical, Therapeutic, Evolutionary and Prognostic Aspects in Younger and Elderly Patients
AUTHORS:
Kone Djakaridja, Kadiane-Oussou Juliette, Akanji Iburaima Alamun, Yapo Martine Tatiana, Kouamé Kouamé Gilles Renaud, Karidioula Jean Marie, Adou Leioh Romeo, Kone Famoussa, Sule Mutiyu Akanbi, Soumahoro Namory Junior, Aba Yapo Thomas, Kra Ouffoue
KEYWORDS:
Epidemiology, Coronavirus, SARS-Cov2, Age, Bouaké
JOURNAL NAME:
Advances in Infectious Diseases,
Vol.12 No.2,
June
21,
2022
ABSTRACT: Introduction: The clinical manifestations of many diseases vary with age, and older people often do not show typical symptoms of the disease. The present study aims to compare the epidemiological, clinical, therapeutic and evolutionary aspects of elderly patients with COVID-19 compared to young adult patients and to identify risk factors for mortality. Patients and Methods: This was a retrospective single-center analytical study conducted from January 27, 2021 to January 27, 2022 at the COVID-19 Care Center of the Infectious and Tropical Diseases Department of the Bouaké University Teaching Hospital. The study population consisted of all patients aged at least 18 years seen in consultation and/or hospitalized with a positive COVID-19 RT-PCR. The patients were divided into two groups: younger patients (Results: Of a total of 779 patients, 644 (82.7%) were young. The median age of all patients was 41 years (IQR 32 - 54, extreme 18 and 96). Of all the patients 38.5% had a comorbidity. Compared to younger patients, chronic heart disease (61.7% vs 21.5%; p Conclusion: Elderly people with COVID-19 have a different clinical presentation from younger, characterized by more atypical symptoms. Mortality risk factors are age, dyspnoea, impaired consciousness and fever. It is therefore necessary to act on its various factors to improve the prognosis of COVID-19 in this age group.